(PharmaNewsWire.Com, January 24, 2017 ) Publisher's clinical trial report, "Blepharospasm Global Clinical Trials Review, H2, 2016" provides an overview of Blepharospasm clinical trials scenario. This report provides top line data relating to the clinical trials on Blepharospasm. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Publisher Clinical Trial Reports are generated using Publisher's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
- The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months
Reasons to buy
- Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level
List of Tables 3 List of Figures 3 Report Guidance 4 Clinical Trials by Region 5 Clinical Trials and Average Enrollment by Country 6 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 8 Top Five Countries Contributing to Clinical Trials in Europe 9 Top Countries Contributing to Clinical Trials in North America 10 Clinical Trials by G7 Countries: Proportion of Blepharospasm to Ophthalmology Clinical Trials 11 Clinical Trials by Phase in G7 Countries 12 Clinical Trials in G7 Countries by Trial Status 13 Clinical Trials by E7 Countries: Proportion of Blepharospasm to Ophthalmology Clinical Trials 14 Clinical Trials by Phase in E7 Countries 15 Clinical Trials by Phase 16 In Progress Trials by Phase 17 Clinical Trials by Trial Status 18 Clinical Trials by End Point Status 19 Subjects Recruited Over a Period of Time 20 Clinical Trials by Sponsor Type 21 Prominent Sponsors 22 Top Companies Participating in Blepharospasm Therapeutics Clinical Trials 23 Prominent Drugs 25 Clinical Trial Profile Snapshots 26 Appendix 40 Abbreviations 40 Definitions 40 Research Methodology 41 Secondary Research 41 About Publisher 42 Contact Us 42 Disclaimer 42 Source 43
Companies Mentioned:
Merz Pharma GmbH & Co KgaA Allergan Plc Ipsen SA Pacific Corporation Medy-Tox Inc MAPI Developpement SAS JIN CO LTD Hugel Pharma Co Ltd GlaxoSmithKline Plc Daewoong Pharmaceutical Co Ltd
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
